Literature DB >> 8596046

Prostaglandin E2 stimulates osteoclast formation via endogenous IL-1 beta expressed through protein kinase A.

S Amano1, K Naganuma, Y Kawata, K Kawakami, S Kitano, S Hanazawa.   

Abstract

The present study was conducted to determine whether endogenous IL-1 is involved as a potent mediator of PGE2-stimulated osteoclast formation in 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25-(OH)2D3)-primed calvarial cells from mouse embryos. PGE2 induced IL-1 beta gene expression in the primed calvarial cells. IL-1 beta gene expression was also induced in a dose-dependent manner by forskolin and dibutyryl cAMP. PGE2-induced IL-1 beta gene expression was markedly inhibited by H-89, a potent inhibitor of protein kinase A. On the other hand, osteoclast formation in 1 alpha,25-(OH)2D3-primed calvarial cells was also stimulated by forskolin and dibutyryl cAMP, and their stimulatory effects were dose dependent. H-89 also inhibited PGE2-stimulated osteoclast formation. The presence of the IL-1 beta gene product in the conditioned medium of 1 alpha,25-(OH)2D3-primed calvarial cells treated with PGE2 was proved by the results of an immunoprecipitation assay using anti-mouse IL-1 beta Ab. The addition of anti-mouse IL-1 beta Ab to 1 alpha,25-(OH)2D3 primed calvarial cell cultures markedly inhibited PGE2-stimulated osteoclast formation. The stimulatory effect of conditioned medium of primed calvarial cells treated with PGE2 on osteoclast formation was also inhibited by anti-IL-1 beta Ab pretreatment. Furthermore, we found that endogenous IL-6 is partially involved in PGE2-stimulated osteoclast formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596046

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Inhibition by 16,16-dimethyl prostaglandin E2 of tumor necrosis factor-alpha and interleukin-1beta production and messenger RNA expression in human monocytes stimulated by Helicobacter pylori.

Authors:  O Takaishi; T Arakawa; Y Fujiwara; T Fukuda; K Otani; K Yamasaki; K Higuchi; T Kuroki
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells.

Authors:  Eri Katsuyama; Hiroya Miyamoto; Tami Kobayashi; Yuiko Sato; Wu Hao; Hiroya Kanagawa; Atsuhiro Fujie; Toshimi Tando; Ryuichi Watanabe; Mayu Morita; Kana Miyamoto; Yasuo Niki; Hideo Morioka; Morio Matsumoto; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

3.  Actin and ERK1/2-CEBPβ signaling mediates phagocytosis-induced innate immune response of osteoprogenitor cells.

Authors:  Heon Goo Lee; Hiroshi Minematsu; Kyung Ok Kim; Ayse B Celil Aydemir; Mike J Shin; Saqib A Nizami; Kook Jin Chung; Anny C Hsu; Christopher R Jacobs; Francis Youngin Lee
Journal:  Biomaterials       Date:  2011-09-06       Impact factor: 12.479

4.  Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts.

Authors:  Nathalie Amiable; Steeve Kwan Tat; Daniel Lajeunesse; Nicolas Duval; Jean-Pierre Pelletier; Johanne Martel-Pelletier; Christelle Boileau
Journal:  Bone       Date:  2009-03-02       Impact factor: 4.398

Review 5.  Type of article: Review article the role of osteocytes-specific molecular mechanism in regulation of mechanotransduction - A systematic review.

Authors:  Meng Chen Michelle Li; Simon Kwoon Ho Chow; Ronald Man Yeung Wong; Ling Qin; Wing Hoi Cheung
Journal:  J Orthop Translat       Date:  2021-05-13       Impact factor: 5.191

6.  Involvement of cyclooxygenase-2--prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells.

Authors:  Hisashi Takehara; Junichi Iwamoto; Jun-Ichi Iwamoto; Yuji Mizokami; Kimiko Takahashi; Toshiya Ootubo; Syuuhei Miura; Toshiaki Narasaka; Hiroki Takeyama; Takayuki Omata; Koichi Shimokobe; Masanori Ito; Takeshi Matsuoka
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.